US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Paradigm Biopharmaceuticals Ltd (PAR) 銘柄情報

Paradigm Biopharmaceuticals Ltd (PAR)

0.145

-0.005

(-3.33%)

終了 6月5日 3:00PM

Paradigm Biopharmaceuticals Ltd (PAR) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.145

( -3.33% )

買値

0.145

売値

0.15

出来高

1,714,704

0.145 日の範囲 0.1475

0.145 52 週間の範囲 0.48

時価総額

前日終値

0.15

始値

0.145

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 1,576,739

発行済株式数

525,456,672

配当利回り

PER

-1.67

1 株当たり利益 (EPS)

-0.1

歳入

8.45k

純利益

-36.09M

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya vir... Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.paradigmbiopharma.com

本社

Melbourne, Australia

設立

2026

Paradigm Biopharmaceuticals Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker PAR. The last closing price for Paradigm Biopharmaceutic... was AUD0.15. Over the last year, Paradigm Biopharmaceutic... shares have traded in a share price range of AUD 0.145 to AUD 0.48.

Paradigm Biopharmaceutic... currently has 525,456,672 shares in issue. The market capitalisation of Paradigm Biopharmaceutic... is AUD76.19 million. Paradigm Biopharmaceutic... has a price to earnings ratio (PE ratio) of -1.67.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.025	-14.7058823529	0.17	0.17	0.145	2463806	0.16099172	DE
4	-0.035	-19.4444444444	0.18	0.185	0.145	1418982	0.16826706	DE
12	-0.105	-42	0.25	0.295	0.145	1730977	0.19944145	DE
26	-0.2	-57.9710144928	0.345	0.37	0.145	1297068	0.24090963	DE
52	-0.155	-51.6666666667	0.3	0.48	0.145	1141221	0.29183208	DE
156	-0.705	-82.9411764706	0.85	1.095	0.145	1050472	0.37066209	DE
260	-2.005	-93.2558139535	2.15	2.69	0.145	870799	0.68856472	DE

PAR - Frequently Asked Questions (FAQ)

What is the current Paradigm Biopharmaceuticals Ltd share price?

The current share price of Paradigm Biopharmaceuticals Ltd is AUD 0.145

How many Paradigm Biopharmaceuticals Ltd shares are in issue?

Paradigm Biopharmaceuticals Ltd has 525,456,672 shares in issue

What is the market cap of Paradigm Biopharmaceuticals Ltd?

The market capitalisation of Paradigm Biopharmaceuticals Ltd is AUD 76.19M

What is the 1 year trading range for Paradigm Biopharmaceuticals Ltd share price?

Paradigm Biopharmaceuticals Ltd has traded in the range of AUD 0.145 to AUD 0.48 during the past year

What is the PE ratio of Paradigm Biopharmaceuticals Ltd?

The price to earnings ratio of Paradigm Biopharmaceuticals Ltd is -1.67

What is the cash to sales ratio of Paradigm Biopharmaceuticals Ltd?

The cash to sales ratio of Paradigm Biopharmaceuticals Ltd is 10.88k

What is the registered address of Paradigm Biopharmaceuticals Ltd?

The registered address for Paradigm Biopharmaceuticals Ltd is 500 Collins Street, Melbourne, Victoria, 3000

What is the Paradigm Biopharmaceuticals Ltd website address?

The website address for Paradigm Biopharmaceuticals Ltd is www.paradigmbiopharma.com

Which industry sector does Paradigm Biopharmaceuticals Ltd operate in?

Paradigm Biopharmaceuticals Ltd operates in the Biotechnology & Life Sciences sector

1plus1

HEAVY TRADING COMING THRU

Pittkid

Pittkid 5分前

Walter4

Walter4 5分前

Shareholders face total losses when "investing" in Jake P. Noch-affiliated companies due to the highly dilutive compensation plans and "dollar-denominated" court settlements that rely on dumping stock on the open market. These questionable payouts allow Noch to sell millions of shares directly to re

fredscott36

fredscott36 5分前

.......hill and reed....??....whatever the F**K that means.......'sposed to be closing out NAOMI LIBOR APPEAL, WaMu-R, UWB-R. and all related nasties......??...

.....down the road....??.....hill and reed, again.......getting a MEGA-BANK to gobble up frankie's failing credi

ollik78

ollik78 5分前

BNAI Green in the red sea 📈🚬

Genz2

No bonus??? They should start taking away their salaries or fire them!!!!

OCKHAM'S RAZOR

OCKHAM'S RAZOR 5分前

https://investorshub.advfn.com/boards/manage_msg.asp?message_id=177674741

LeAcc

jcromeenes

jcromeenes 7分前

Fannie now as well.

BEIJING BILL

BEIJING BILL 7分前

I'm holding until their golden get it .. "golden" .. mining .. metals ... Chee Chee cheeee

katiesdad7

katiesdad7 7分前

L2 looking better today. LFG

glenn1919

glenn1919 7分前

slapthatdark.............otc..........................https://stockcharts.com/sc3/ui/?s=BINI&p=w&yr=1&mn=3&dy=0&id=p96837884856

imanjen13

imanjen13 8分前

My hope is that Elite is merges with a company like Teva with shareholders given shares in exchange. This would allow shareholders to have a margin account, have the possibility to sell options against their position, and not have to pay a capital gain until they sold shares.

Truthsocial

Truthsocial 8分前

Looks like we are on the fast track ....

It may not be 30 day wait.....

glenn1919

glenn1919 8分前

RMSG.......LASE.......BCDA......IONZ........ACCL........DEVS........SMTK............https://stockcharts.com/sc3/ui/?s=SMTK&p=w&yr=1&mn=3&dy=0&id=p96837884856

BEIJING BILL

BEIJING BILL 8分前

Steady as she goes. Paytience

meixatech

meixatech 9分前

No, they think I am following neurology-oriented companies as a casual hobby.

work-n-hard

work-n-hard 9分前

https://investorshub.advfn.com/uimage/uploads/2026/6/5/qwmscScreenshot_2026-06-05_at_10-11-21_HIRU_SharpCharts_StockCharts.com.png

US Market News

US Market News 9分前

Vida Global Honored with 2026 MSP Today Product of the Year AwardJune 5, 2026 10:00 AM
Business Wire Vida's AI Agent OS Recognized for Real World Impact and Channel Innovation

US Market News

US Market News 9分前

Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming FirstJune 5, 2026 10:00 AM
PR Newswire (US) Telemundo's live Spanish-language coverage will stream in Dolby Vision and Dolby Atmos wit

mike_dotcom

mike_dotcom 9分前

Just another schitty day, schitty week, schitty month, schitty year, schitty decade. Heading back to a new all time low. Nothing to stop it. Oh, and yet another schitty useless patent.

i_like_bb_stock

i_like_bb_stock 9分前

$APM gearing up here into Tuesday’s merger vote they get 30% of the deal extremely high compared to other mergers ran to almost $5 when this was announced should be a nice mover

Joe Kaplan

Joe Kaplan 9分前

Looking like AU, AG, are relics again with little value. Pretty to look at. Get in the TRILLION $ MC techs.
/s

DJknows

DJknows 9分前

Yves' like on a photonics industry post, the Blum like on the Teramount/CPO supply chain acquisition, and the Computex narrative all seem to be pointing at the same thing from different angles: the secular tailwind that LWLG's thesis depends on is not theoretical anymore. It is now the explicit publ

Paradigm Biopharmaceutic...

Grupo Rcfa Fundo DE Inve...

Voltage Metals (PK)

The Progressive

Yoma Strategic (PK)

Himalaya Technologies (EM)

Sino Ocean Land (PK)

DJ Commodity Index TR

Tree Island Steel

Ivanhoe Mines (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。